Invention Grant
- Patent Title: Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
-
Application No.: US12816995Application Date: 2010-06-16
-
Publication No.: US08343989B2Publication Date: 2013-01-01
- Inventor: James P. Edwards , David E. Kindrachuk , Christopher M. Mapes , Daniel J. Pippel , Jennifer D. Venable
- Applicant: James P. Edwards , David E. Kindrachuk , Christopher M. Mapes , Daniel J. Pippel , Jennifer D. Venable
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/4184
Abstract:
Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
Public/Granted literature
- US20100256373A1 BENZOIMIDAZOL-2-YL PYRIMIDINES AND PYRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR Public/Granted day:2010-10-07
Information query
